339 related articles for article (PubMed ID: 10847561)
21. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence.
Reiter RJ; Tan DX; Manchester LC; Qi W
Cell Biochem Biophys; 2001; 34(2):237-56. PubMed ID: 11898866
[TBL] [Abstract][Full Text] [Related]
22. Notoginsenoside R1 attenuates amyloid-β-induced damage in neurons by inhibiting reactive oxygen species and modulating MAPK activation.
Ma B; Meng X; Wang J; Sun J; Ren X; Qin M; Sun J; Sun G; Sun X
Int Immunopharmacol; 2014 Sep; 22(1):151-9. PubMed ID: 24975829
[TBL] [Abstract][Full Text] [Related]
23. Melatonin defeats neurally-derived free radicals and reduces the associated neuromorphological and neurobehavioral damage.
Reiter RJ; Tan DX; Manchester LC; Tamura H
J Physiol Pharmacol; 2007 Dec; 58 Suppl 6():5-22. PubMed ID: 18212398
[TBL] [Abstract][Full Text] [Related]
24. Melatonin prevents amyloid protofibrillar induced oxidative imbalance and biogenic amine catabolism.
Gunasingh MJ; Philip JE; Ashok BS; Kirubagaran R; Jebaraj WC; Davis GD; Vignesh S; Dhandayuthapani S; Jayakumar R
Life Sci; 2008 Jul; 83(3-4):96-102. PubMed ID: 18590917
[TBL] [Abstract][Full Text] [Related]
25. Melatonin prevents glutamate-induced oxytosis in the HT22 mouse hippocampal cell line through an antioxidant effect specifically targeting mitochondria.
Herrera F; Martin V; García-Santos G; Rodriguez-Blanco J; Antolín I; Rodriguez C
J Neurochem; 2007 Feb; 100(3):736-46. PubMed ID: 17263795
[TBL] [Abstract][Full Text] [Related]
26. Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans.
Reiter RJ; Tan DX; Mayo JC; Sainz RM; Leon J; Czarnocki Z
Acta Biochim Pol; 2003; 50(4):1129-46. PubMed ID: 14740000
[TBL] [Abstract][Full Text] [Related]
27. Protective roles of melatonin against the amyloid-dependent development of Alzheimer's disease: A critical review.
Vincent B
Pharmacol Res; 2018 Aug; 134():223-237. PubMed ID: 29981776
[TBL] [Abstract][Full Text] [Related]
28. (-)-Meptazinol-melatonin hybrids as novel dual inhibitors of cholinesterases and amyloid-β aggregation with high antioxidant potency for Alzheimer's therapy.
Cheng S; Zheng W; Gong P; Zhou Q; Xie Q; Yu L; Zhang P; Chen L; Li J; Chen J; Chen H; Chen H
Bioorg Med Chem; 2015 Jul; 23(13):3110-8. PubMed ID: 26025073
[TBL] [Abstract][Full Text] [Related]
29. Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease.
Polidori MC; Griffiths HR; Mariani E; Mecocci P
Amino Acids; 2007; 32(4):553-9. PubMed ID: 17273806
[TBL] [Abstract][Full Text] [Related]
30. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity.
Varadarajan S; Yatin S; Aksenova M; Butterfield DA
J Struct Biol; 2000 Jun; 130(2-3):184-208. PubMed ID: 10940225
[TBL] [Abstract][Full Text] [Related]
31. Suppression of oxygen toxicity by melatonin.
Reiter RJ; Tan DX; Qi WB
Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):575-81. PubMed ID: 10437151
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotective role of melatonin in oxidative stress vulnerable brain.
Gupta YK; Gupta M; Kohli K
Indian J Physiol Pharmacol; 2003 Oct; 47(4):373-86. PubMed ID: 15266948
[TBL] [Abstract][Full Text] [Related]
33. Alzheimer's disease: pathological mechanisms and the beneficial role of melatonin.
Rosales-Corral SA; Acuña-Castroviejo D; Coto-Montes A; Boga JA; Manchester LC; Fuentes-Broto L; Korkmaz A; Ma S; Tan DX; Reiter RJ
J Pineal Res; 2012 Mar; 52(2):167-202. PubMed ID: 22107053
[TBL] [Abstract][Full Text] [Related]
34. A potential role for crystallization inhibitors in treatment of Alzheimer's disease.
Grases F; Costa-Bauzà A; Prieto RM
Med Hypotheses; 2010 Jan; 74(1):118-9. PubMed ID: 19666212
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial oxidative stress index, activity of redox-sensitive aconitase and effects of endogenous anti- and pro-oxidants on its activity in control, Alzheimer's disease and Swedish Familial Alzheimer's disease brain.
Raukas M; Rebane R; Mahlapuu R; Jefremov V; Zilmer K; Karelson E; Bogdanovic N; Zilmer M
Free Radic Res; 2012 Dec; 46(12):1490-5. PubMed ID: 22962855
[TBL] [Abstract][Full Text] [Related]
36. Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction.
Ressmeyer AR; Mayo JC; Zelosko V; Sáinz RM; Tan DX; Poeggeler B; Antolín I; Zsizsik BK; Reiter RJ; Hardeland R
Redox Rep; 2003; 8(4):205-13. PubMed ID: 14599344
[TBL] [Abstract][Full Text] [Related]
37. Role of melatonin in neurodegenerative diseases.
Srinivasan V; Pandi-Perumal SR; Maestroni GJ; Esquifino AI; Hardeland R; Cardinali DP
Neurotox Res; 2005; 7(4):293-318. PubMed ID: 16179266
[TBL] [Abstract][Full Text] [Related]
38. Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid.
Chyan YJ; Poeggeler B; Omar RA; Chain DG; Frangione B; Ghiso J; Pappolla MA
J Biol Chem; 1999 Jul; 274(31):21937-42. PubMed ID: 10419516
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of neuroprotection of melatonin against beta-amyloid neurotoxicity.
Ionov M; Burchell V; Klajnert B; Bryszewska M; Abramov AY
Neuroscience; 2011 Apr; 180():229-37. PubMed ID: 21354274
[TBL] [Abstract][Full Text] [Related]
40. Melatonin acts as antioxidant and pro-oxidant in an organotypic slice culture model of Alzheimer's disease.
Clapp-Lilly KL; Smith MA; Perry G; Harris PL; Zhu X; Duffy LK
Neuroreport; 2001 May; 12(6):1277-80. PubMed ID: 11338206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
